Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.98+0.02 (+2.50%)
Close on Nov 18, 2026Market cap $11.49MP/E –Yield –
Bionano Genomics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Bionano Genomics's pe ratio was 0.1× on Oct 31, 2018.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Oct 31, 2018 | 0.1× | – |
See a number that looks wrong?